Seminoma: Risk-Adapted Strategy Could Mean Less Toxic Chemo Seminoma: Risk-Adapted Strategy Could Mean Less Toxic Chemo
Early use of FDG-PET in chemotherapy can identify men with low-volume seminoma who have highly chemosensitive disease, enabling them to safely skip the standard chemotherapy regimen with its toxicity.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Chemotherapy | Health | Hematology | Seminoma | Testicular Cancer | Toxicology